Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study.
Cong XiePeter IrogaMichelle J BoundJacqueline GrivellWeikun HuangKaren Louise JonesMichael HorowitzChristopher K RaynerChinmay S MarathePublished in: Diabetologia (2024)
www.anzctr.org.au ACTRN12621000878875 FUNDING: The study was not funded by a specific research grant.
Keyphrases
- type diabetes
- placebo controlled
- double blind
- clinical trial
- study protocol
- open label
- cardiovascular disease
- glycemic control
- sensitive detection
- phase ii
- insulin resistance
- phase iii
- randomized controlled trial
- blood glucose
- metabolic syndrome
- squamous cell carcinoma
- radiation therapy
- phase ii study
- blood pressure
- quantum dots